Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Depreciation & Amortization (CF) of $13640.0 for Q2 2026, down 7.81% on a QoQ basis from $14796.0 in Q1 2026, and down 27.7% year-over-year from $18866.0 in Q2 2025.
Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $13640.0 for Q2 2026.
- Quarterly Depreciation & Amortization (CF) fell 27.7% year-over-year to $13640.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $59997.0 (up 54.54% YoY) and the FY2025 annual result came in at $59866.0, up 156.81% from the prior year.
- Depreciation & Amortization (CF) was $13640.0 for Q2 2026 at Pharma-Bio Serv, down from $14796.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $18866.0 in Q2 2025 and bottomed at $4589.0 in Q3 2024.
- A 5-year average of $11711.4 and a median of $12881.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) plunged 59.75% — and 2025, when it soared 243.08%.
- Pharma-Bio Serv's Depreciation & Amortization (CF) stood at $12800.0 in 2022, then slumped by 42.25% to $7392.0 in 2023, then decreased by 19.81% to $5928.0 in 2024, then surged by 166.82% to $15817.0 in 2025, then slipped by 13.76% to $13640.0 in 2026.
- Business Quant data shows PBSV's Depreciation & Amortization (CF) at $13640.0 in Q2 2026, $14796.0 in Q1 2026, and $15817.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.43 Bn | 24.12 Bn | 662.02 Mn | 11.59 Mn |
| 2 | BrightSpring Health Services | 14.97 Bn | 14.07 Bn | 482.22 Mn | 39.09 Mn |
| 3 | Healthequity | 8.13 Bn | 7.86 Bn | 256.31 Mn | 38.21 Mn |
| 4 | 10x Genomics | 5.98 Bn | 5.44 Bn | 106.18 Mn | 9.96 Mn |
| 5 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn | 1.17 Mn |
| 6 | Waystar Holding | 4.43 Bn | 4.37 Bn | 216.84 Mn | 41.45 Mn |
| 7 | MiniMed | 4.38 Bn | 4.08 Bn | 480.00 Mn | 39.00 Mn |
| 8 | Doximity | 3.91 Bn | 3.16 Bn | 125.97 Mn | 4.13 Mn |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - | 146,000.00 |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | 13,640.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 13,640.00 |
| Apr 30, 2026 | 13,640.00 |
| Jan 31, 2026 | 14,796.00 |
| Jan 31, 2026 | 14,796.00 |
| Oct 31, 2025 | 15,817.00 |
| Oct 31, 2025 | 15,817.00 |
| Jul 31, 2025 | 15,744.00 |
| Jul 31, 2025 | 15,744.00 |
| Apr 30, 2025 | 18,866.00 |
| Apr 30, 2025 | 18,866.00 |
| Jan 31, 2025 | 9,439.00 |
| Jan 31, 2025 | 9,439.00 |
| Oct 31, 2024 | 5,928.00 |
| Oct 31, 2024 | 5,928.00 |
| Jul 31, 2024 | 4,589.00 |
| Jul 31, 2024 | 4,589.00 |
| Apr 30, 2024 | 5,508.00 |
| Apr 30, 2024 | 5,508.00 |
| Jan 31, 2024 | 7,286.00 |
| Jan 31, 2024 | 7,286.00 |